A landmark clinical trial testing the effect of microdosing LSD on symptoms of attention-deficit hyperactive disorder (ADHD) recently delivered its first data readout and the results have been ...

Taking small, repeated doses of the psychedelic drug LSD doesn’t alleviate ADHD symptoms any more than a placebo. To test the drugs’ effects on ADHD more rigorously, Matthias Liechti at the University ...

LSD has shown promise for treating conditions like depression, but it might not do much for ADHD. © cybermagician via Shutterstock LSD can do a lot of things, but ...

In this randomized study, microdosing LSD was not more effective than placebo in reducing ADHD symptoms in adults. Repeated doses of the low-dose LSD were safe in an outpatient setting.

Microdosing is gaining popularity with a new breed of health seekers. These self-experimenters take a very small amount of psilocybin mushrooms or LSD to try to reduce anxiety, stress and depression.

VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO), through its scientific collaborators, has published its first Peer Reviewed Paper in Biological ...

Depending on your experience with psychedelic drugs, the idea of microdosing as a form of therapy might sound either terrifying or like the best Tuesday ever. But before you start adding mushrooms to ...

Microdosing psychedelics, which involves ingesting sub-threshold doses of substances like lysergic acid diethylamide (LSD), psilocybin, or 3,4-Methylenedioxymethamphetamine (MDMA) multiple times a ...

BAN AND UNIVERSAL BACKGROUND CHECKS. WELL, IT’S A TOPIC THAT’S BEEN GAINING POPULARITY MICRODOSING WITH PSYCHEDELICS. NOW KOAT U-N-M HEALTH EXPERT DOCTOR ASH SPOKE WITH DARLENE MELENDEZ ABOUT THIS AND ...

Microdosing is gaining popularity with a new breed of health seekers. These self-experimenters take a very small amount of psilocybin mushrooms or lysergic acid diethylamide (LSD) to try to reduce ...

VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO), through its scientific collaborators, has published its first Peer Reviewed Paper in Biological ...